MADISON, Wis.–Third Wave Technologies Inc. (NASDAQ:TWTI) today announced that it has agreed to acquire Stratagene’s Full Velocity family of worldwide patents and patent applications from Agilent Technologies Inc., Santa Clara, Calif. Third Wave’s acquisition of the Full Velocity patents strengthens the company’s intellectual property position for Invader Plus®, which couples the Invader chemistry with PCR. […]
AMSTERDAM, Netherlands and SANTA CLARA, Calif., April 22 — Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, and Agilent Technologies, Inc. (NYSE: A), today announced terms under which they intend to collaborate to develop new in-vitro diagnostic tests. In addition, the two companies announced an agreement in which Agendia products […]
Distinguished Laboratory Director Joins Company to Drive Quality and Growth in Neonatal and Prenatal Service Business WALTHAM, Mass.–PerkinElmer, Inc. (NYSE: PKI – News), a global technology leader in Health Sciences and Photonics, today announced that John E. Sherwin, Ph.D., has joined the Company as director of laboratory operations for its genetic screening business, reporting to […]
WALTHAM, Mass.–PerkinElmer, Inc. (NYSE: PKI – News), a global leader in Health Sciences, today announced the signing of a definitive agreement with Pediatrix Medical Group, Inc. (NYSE: PDX – News) under which PerkinElmer will acquire the newborn metabolic screening business of Pediatrix in a cash transaction. The acquisition is expected to have no material effect […]
FORT LAUDERDALE, Fla.–Dec. 19, 2007–Pediatrix Medical Group, Inc., (NYSE:PDX) has entered into a definitive agreement to sell its newborn metabolic screening laboratory to PerkinElmer, Inc., (NYSE:PKI). Specific terms of the cash transaction were not disclosed. Pediatrix will focus its resources to support the continued expansion of its clinical and administrative competencies within the physician services […]
Expands Neonatal Product Range and Clinical Reach WALTHAM, Mass. & CAMBRIDGE, Mass.–PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences, and ViaCell, Inc. (Nasdaq: VIAC), a biotechnology company specializing in the collection and preservation of umbilical cord blood stem cells, announced today the signing of a definitive agreement under which PerkinElmer plans to […]
Creating Market and Technology Leader in Molecular Diagnostics Transaction Valued at Approximately US$1.6 Billion Expected to be Accretive in 2008 to QIAGEN’s Earnings Per Share Venlo, The Netherlands and Gaithersburg, Md., USA — June 3, 2007 – QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) and Digene Corp. (Nasdaq: DIGE) announced today a definitive agreement […]
HERCULES, CA – October 16, 2006 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the acquisition of Blackhawk BioSystems, Inc., a San Ramon, California, based manufacturer of quality control products for use in laboratories that perform […]
BIOWIRE2K LA JOLLA, Calif.–Aug. 14, 2006–Stratagene Corporation (Nasdaq:STGN), a developer, manufacturer and marketer of specialized life science research and diagnostics products, announced today that it has entered into a joint development and license agreement with Rosetta Inpharmatics LLC, a wholly-owned subsidiary of Merck & Co., Inc., to create an automated solution for the isolation of […]
Boston, MA 7/27/06—PerkinElmer has acquired two companies for a total of$56.7 million to add to its Genetic Screening business. It has acquired N.N.Macri Technologies, which holds patents related to free beta Human Chori-onic Gonadotropin (free Beta hCG), a peptide hormone recognized as abiomarker for trimester prenatal risk assessment. PerkinElmer also has acquired NTD Laboratories, a […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
